产品编号：T004915
产品规格：5mg
产品价格：面议
| 标准品编号: | T004915 |
| 名称: | TAK-875 |
| 别名: | (3S)-6-[[2',6'-Dimethyl-4'-[3-(methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]methoxy]-2,3-dihydro-3-benzofuranacetic Acid; (+)-TAK 875; |
| CAS号: | 1000413-72-8 |
| 分子式: | C₂₉H₃₂O₇S |
| 外观: | 白色固体 |
| 熔点: | 123-127°C |
| 分子量: | 524.63 |
| 储存: | 冰箱 |
| 溶解度: | DMSO (Slightly), Methanol (Slightly) |
| 类别: | Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | TAK-876 is a selective G protein-coupled receptor 40 (GPR40) agonist (1,2). TAK-876 is a novel oral medication that has been developed to improve the secretion of insulin in a glucose-dependent manner, which has the potential to improve the control of blood sugar levels with a low risk of hypoglycemia. |
| 参考文献 |
|
